KRISTEN JACKSON: Open Payments
NPI 1316465347 · ELMWOOD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 78 payments from 20 companies in 2025. Trend: 2023 $2,103 · 2024 $1,971 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 20 | $292 |
| Lilly USA, LLC | 9 | $213 |
| Novo Nordisk Inc | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Lundbeck LLC | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
Products named: ZENPEP, JARDIANCE, MOUNJARO, LEQVIO, Ozempic, Kerendia, TRINTELLIX, REXULTI.
Industry payments across IL — which companies pay providers there.
